M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies
Identifieur interne : 001543 ( Main/Exploration ); précédent : 001542; suivant : 001544M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies
Auteurs : Elia Ascer [Brésil] ; Marcus Marques [Brésil] ; Magnus Gidlund [Brésil]Source :
- BMJ Case Reports [ 1757-790X ] ; 2011.
English descriptors
- Teeft :
- Antinuclear factor, Antiphospholipid, Antiphospholipid antibodies, Antiphospholipid syndrome, Body temperature, Case reports, Emergency unit, Further permission, Gure, Hydroxychloroquine sulphate, Inferior portion, Intensive care unit, Laboratory examinations, Paulo, Pharmacological therapy, Pneumoniae, Pneumoniae infection, Positive lupic anticoagulant factor, Productive cough, Pulmonary embolism, Pulmonary scintigraphy, Pulmonary thromboembolism, Reactive protein, Right lung, Severe evolution, Syndrome, Thoracic, Thoracic pain, Thoracic tomography, Thromboembolism.
Abstract
A 28-year-old, hypertensive and hypercholesterolaemic patient, was referred to our emergency unit with a mild thoracic pain, productive cough and a body temperature of 37.3°C. Laboratory examinations showed normal white cell count and moderate elevation of C reactive protein (CRP). Later, the thoracic pain increased accompanied by shortness of breath. High D-dimer was detected. Positive lupic anticoagulant factor and anticardiolipin and antibodies anti-Mycoplasma pneumoniae were present and high titres of antinuclear factor. Recombinant tissue-type plasminogen activator plus heparin and vancomycin were administered due the high possibility of mycoplasma pneumonia associated with pulmonary thromboembolism. CRP increased to very high levels with very mild modification of white blood cells during the evolution. Thoracic tomography and pulmonary scintigraphy of the lungs confirmed the diagnosis. The patient responded well and he was discharged after 25 days medicated with hydroxychloroquine sulphate, warfarin and aspirin. At present date he is well (150 days).
Url:
DOI: 10.1136/bcr.12.2010.3561
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001132
- to stream Istex, to step Curation: 001132
- to stream Istex, to step Checkpoint: 000519
- to stream Main, to step Merge: 001545
- to stream Main, to step Curation: 001543
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies</title>
<author><name sortKey="Ascer, Elia" sort="Ascer, Elia" uniqKey="Ascer E" first="Elia" last="Ascer">Elia Ascer</name>
</author>
<author><name sortKey="Marques, Marcus" sort="Marques, Marcus" uniqKey="Marques M" first="Marcus" last="Marques">Marcus Marques</name>
</author>
<author><name sortKey="Gidlund, Magnus" sort="Gidlund, Magnus" uniqKey="Gidlund M" first="Magnus" last="Gidlund">Magnus Gidlund</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A476456A83DA9A6DFF7A74CEF44817DB852F0EA8</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1136/bcr.12.2010.3561</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-3F950W9H-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001132</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001132</idno>
<idno type="wicri:Area/Istex/Curation">001132</idno>
<idno type="wicri:Area/Istex/Checkpoint">000519</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000519</idno>
<idno type="wicri:Area/Main/Merge">001545</idno>
<idno type="wicri:Area/Main/Curation">001543</idno>
<idno type="wicri:Area/Main/Exploration">001543</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies</title>
<author><name sortKey="Ascer, Elia" sort="Ascer, Elia" uniqKey="Ascer E" first="Elia" last="Ascer">Elia Ascer</name>
<affiliation wicri:level="4"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Immunology, University of Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
<orgName type="university">Université de São Paulo</orgName>
</affiliation>
</author>
<author><name sortKey="Marques, Marcus" sort="Marques, Marcus" uniqKey="Marques M" first="Marcus" last="Marques">Marcus Marques</name>
<affiliation wicri:level="3"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Biomedicine, Ciência e Sáude, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gidlund, Magnus" sort="Gidlund, Magnus" uniqKey="Gidlund M" first="Magnus" last="Gidlund">Magnus Gidlund</name>
<affiliation wicri:level="4"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Immunology, University of Sao Paulo, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
<orgName type="university">Université de São Paulo</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">BMJ Case Reports</title>
<title level="j" type="abbrev">BMJ Case Reports</title>
<idno type="eISSN">1757-790X</idno>
<imprint><publisher>BMJ Publishing Group Ltd</publisher>
<date type="published" when="2011">2011</date>
<biblScope unit="volume">2011</biblScope>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Antinuclear factor</term>
<term>Antiphospholipid</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Body temperature</term>
<term>Case reports</term>
<term>Emergency unit</term>
<term>Further permission</term>
<term>Gure</term>
<term>Hydroxychloroquine sulphate</term>
<term>Inferior portion</term>
<term>Intensive care unit</term>
<term>Laboratory examinations</term>
<term>Paulo</term>
<term>Pharmacological therapy</term>
<term>Pneumoniae</term>
<term>Pneumoniae infection</term>
<term>Positive lupic anticoagulant factor</term>
<term>Productive cough</term>
<term>Pulmonary embolism</term>
<term>Pulmonary scintigraphy</term>
<term>Pulmonary thromboembolism</term>
<term>Reactive protein</term>
<term>Right lung</term>
<term>Severe evolution</term>
<term>Syndrome</term>
<term>Thoracic</term>
<term>Thoracic pain</term>
<term>Thoracic tomography</term>
<term>Thromboembolism</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A 28-year-old, hypertensive and hypercholesterolaemic patient, was referred to our emergency unit with a mild thoracic pain, productive cough and a body temperature of 37.3°C. Laboratory examinations showed normal white cell count and moderate elevation of C reactive protein (CRP). Later, the thoracic pain increased accompanied by shortness of breath. High D-dimer was detected. Positive lupic anticoagulant factor and anticardiolipin and antibodies anti-Mycoplasma pneumoniae were present and high titres of antinuclear factor. Recombinant tissue-type plasminogen activator plus heparin and vancomycin were administered due the high possibility of mycoplasma pneumonia associated with pulmonary thromboembolism. CRP increased to very high levels with very mild modification of white blood cells during the evolution. Thoracic tomography and pulmonary scintigraphy of the lungs confirmed the diagnosis. The patient responded well and he was discharged after 25 days medicated with hydroxychloroquine sulphate, warfarin and aspirin. At present date he is well (150 days).</div>
</front>
</TEI>
<affiliations><list><country><li>Brésil</li>
</country>
<region><li>État de São Paulo</li>
</region>
<settlement><li>São Paulo</li>
</settlement>
<orgName><li>Université de São Paulo</li>
</orgName>
</list>
<tree><country name="Brésil"><region name="État de São Paulo"><name sortKey="Ascer, Elia" sort="Ascer, Elia" uniqKey="Ascer E" first="Elia" last="Ascer">Elia Ascer</name>
</region>
<name sortKey="Gidlund, Magnus" sort="Gidlund, Magnus" uniqKey="Gidlund M" first="Magnus" last="Gidlund">Magnus Gidlund</name>
<name sortKey="Marques, Marcus" sort="Marques, Marcus" uniqKey="Marques M" first="Marcus" last="Marques">Marcus Marques</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001543 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001543 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:A476456A83DA9A6DFF7A74CEF44817DB852F0EA8 |texte= M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies }}
This area was generated with Dilib version V0.6.33. |